Zevra Therapeutics Inc.

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Zevra Therapeutics Inc’s recently made public that its Director Bode John B acquired Company’s shares for reported $79624.0 on Mar

Stock Earnings

Zevra Therapeutics Inc’s recently made public that its SVP, Finance & Corp Controller Sangiovanni Timothy J. unloaded Company’s shares for

Insiders Updates

Zevra Therapeutics Inc’s recent filing unveils that its SVP, Finance & Corp Controller Sangiovanni Timothy J. unloaded Company’s shares for

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: Zevra Therapeutics Inc.